US charges two Indian nationals in counterfeit Ozempic distribution scheme
The U.S. Attorney’s Office for the Middle District of Florida and the DOJ’s Criminal Division announced federal charges against Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals, for conspiracy and smuggling in a transnational counterfeit prescription drug scheme.
The investigation was supported by the FDA’s Office of Criminal Investigations, and Acting FDA Commissioner Kyle Diamantas warned that counterfeit drugs pose a direct threat to public health and patient safety.
Court documents allege that between July 2023 and April 2024 the pair obtained fake Ozempic from unauthorized sources in China and distributed it with counterfeit packaging, inserts, pen labels and needles to pharmacies and patients.
The indictment underscores the FDA’s commitment to trace illicit networks across borders and hold accountable those who profit from counterfeit medicines.
This writeup was produced by pharmadog from original reporting by fda press.
Original headline: “FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme”
read at fda press ↗
comments(0)
5-min edit window · permanent after that